Description
Cifclav – CV 325 Tablets is a broad-spectrum antibiotic formulation containing Cefixime Trihydrate IP 50mg and Potassium Clavulanate 31.25mg per 5ml, designed to effectively treat a variety of bacterial infections. Cefixime, a third-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, providing potent activity against gram-positive and gram-negative bacteria. Potassium Clavulanate enhances efficacy by preventing beta-lactamase enzyme-mediated resistance, ensuring reliable treatment even for resistant bacterial strains. Cifclav CV Dry Syrup is ideal for managing respiratory tract infections, ear and throat infections, urinary tract infections, and skin and soft tissue infections. Its palatable dry syrup formulation ensures easy administration for children and adults, improves compliance, and provides rapid relief from infection, fever, and inflammation, supporting faster recovery and overall health.
